|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
2
|
Huang Y, Shen XJ, Zou Q, Wang SP, Tang SM
and Zhang GZ: Biological functions of microRNAs: a review. J
Physiol Biochem. 67:129–139. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen X, Ba Y, Ma L, et al:
Characterization of microRNAs in serum: a novel class of biomarkers
for diagnosis of cancer and other diseases. Cell Res. 18:997–1006.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mitchell PS, Parkin RK, Kroh EM, et al:
Circulating microRNAs as stable blood-based markers for cancer
detection. Proc Natl Acad Sci USA. 105:10513–10518. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang Z, Huang D, Ni S, Peng Z, Sheng W
and Du X: Plasma microRNAs are promising novel biomarkers for early
detection of colorectal cancer. Int J Cancer. 127:118–126. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao H, Shen J, Medico L, Wang D,
Ambrosone CB and Liu S: A pilot study of circulating miRNAs as
potential biomarkers of early stage breast cancer. PLoS One.
5:e137352010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zen K and Zhang CY: Circulating MicroRNAs:
a novel class of biomarkers to diagnose and monitor human cancers.
Med Res Rev. 32:326–348. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Volinia S, Calin GA, Liu CG, et al: A
microRNA expression signature of human solid tumors defines cancer
gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Selcuklu SD, Donoghue MT and Spillane C:
miR-21 as a key regulator of oncogenic processes. Biochem Soc
Trans. 37:918–925. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Z, Li Z, Gao C, et al: miR-21 plays
a pivotal role in gastric cancer pathogenesis and progression. Lab
Invest. 88:1358–1366. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY and
Yan M: microRNA-21 promotes tumor proliferation and invasion in
gastric cancer by targeting PTEN. Oncol Rep. 27:1019–1026.
2012.PubMed/NCBI
|
|
12
|
Chan SH, Wu CW, Li AF, Chi CW and Lin WC:
miR-21 microRNA expression in human gastric carcinomas and its
clinical association. Anticancer Res. 28:907–911. 2008.PubMed/NCBI
|
|
13
|
Motoyama K, Inoue H, Mimori K, et al:
Clinicopathological and prognostic significance of PDCD4 and
microRNA-21 in human gastric cancer. Int J Oncol. 36:1089–1095.
2010.PubMed/NCBI
|
|
14
|
Ueda T, Volinia S, Okumura H, et al:
Relation between microRNA expression and progression and prognosis
of gastric cancer: a microRNA expression analysis. Lancet Oncol.
11:136–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang J, Zheng X, Xu X, et al: Prognostic
significance of miR-181b and miR-21 in gastric cancer patients
treated with S-1/Oxaliplatin or Doxifluridine/Oxaliplatin. PLoS
One. 6:e232712011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim SY, Jeon TY, Choi CI, et al:
Validation of circulating miRNA biomarkers for predicting lymph
node metastasis in gastric cancer. J Mol Diagn. Jun 24–2013.(Epub
ahead of print).
|
|
17
|
Tsujiura M, Ichikawa D, Komatsu S, et al:
Circulating microRNAs in plasma of patients with gastric cancers.
Br J Cancer. 102:1174–1179. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lawrie CH, Gal S, Dunlop HM, et al:
Detection of elevated levels of tumour-associated microRNAs in
serum of patients with diffuse large B-cell lymphoma. Br J
Haematol. 141:672–675. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Song J, Bai Z, Han W, et al:
Identification of suitable reference genes for qPCR analysis of
serum microRNA in gastric cancer patients. Dig Dis Sci. 57:897–904.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zheng Y, Cui L, Sun W, et al: MicroRNA-21
is a new marker of circulating tumor cells in gastric cancer
patients. Cancer Biomark. 10:71–77. 2011.PubMed/NCBI
|
|
21
|
Hsu CM, Lin PM, Wang YM, Chen ZJ, Lin SF
and Yang MY: Circulating miRNA is a novel marker for head and neck
squamous cell carcinoma. Tumour Biol. 33:1933–1942. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Le HB, Zhu WY, Chen DD, et al: Evaluation
of dynamic change of serum miR-21 and miR-24 in pre- and
post-operative lung carcinoma patients. Med Oncol. 29:3190–3197.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Komatsu S, Ichikawa D, Takeshita H, et al:
Circulating microRNAs in plasma of patients with oesophageal
squamous cell carcinoma. Br J Cancer. 105:104–111. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang B and Zhang Q: The expression and
clinical significance of circulating microRNA-21 in serum of five
solid tumors. J Cancer Res Clin Oncol. 138:1659–1666. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lou Y, Yang X, Wang F, Cui Z and Huang Y:
MicroRNA-21 promotes the cell proliferation, invasion and migration
abilities in ovarian epithelial carcinomas through inhibiting the
expression of PTEN protein. Int J Mol Med. 26:819–827.
2010.PubMed/NCBI
|
|
26
|
Li T, Li D, Sha J, Sun P and Huang Y:
MicroRNA-21 directly targets MARCKS and promotes apoptosis
resistance and invasion in prostate cancer cells. Biochem Biophys
Res Commun. 383:280–285. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fassan M, Pizzi M, Giacomelli L, et al:
PDCD4 nuclear loss inversely correlates with miR-21 levels in colon
carcinogenesis. Virchows Arch. 458:413–419. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang P, Zou F, Zhang X, et al: microRNA-21
negatively regulates Cdc25A and cell cycle progression in colon
cancer cells. Cancer Res. 69:8157–8165. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Vickers KC, Palmisano BT, Shoucri BM,
Shamburek RD and Remaley AT: MicroRNAs are transported in plasma
and delivered to recipient cells by high-density lipoproteins. Nat
Cell Biol. 13:423–433. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang K, Zhang S, Weber J, Baxter D and
Galas DJ: Export of microRNAs and microRNA-protective protein by
mammalian cells. Nucleic Acids Res. 38:7248–7259. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
